Xanthine Analogs Suppress <i>Trypanosoma cruzi</i> Infection In Vitro Using PDEs as Targets

<i>Trypanosoma cruzi</i> (<i>T. cruzi</i>), the causative agent of Chagas disease, has infected 6 million people, putting 70 million people at risk worldwide. Presently, very limited drugs are available, and these have severe side effects. Hence, there is an urgency to delve into other pathways and...

Descrición completa

Detalles Bibliográficos

Principais autores:	Amita R. Banga, Konjeti R. Sekhar, Kayla J. Rayford, Ashutosh Arun, Peace Odiase, Amar P. Garg, Maria F. Lima, Pius N. Nde, Fernando Villalta, Girish Rachakonda
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2022-09-01
Series:	Microbiology Research
Assuntos:	cAMP cGMP phosphodiesterase (PDE) Chagas disease green fluorescent protein (GFP) <i>Trypanosoma cruzi</i> strains
Acceso en liña:	https://www.mdpi.com/2036-7481/13/4/52
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!